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Abstract
Heterotopic ossification is a condition affecting an appreciable
minority of critical care patients; it can have long-lasting effects on
recovery and return to functional status. Ectopic bone forms in soft
tissues near the large joints, causing pain, swelling, limitation of
movement and ultimate disability. X-ray changes may be delayed
for several weeks after the diagnosis is clinically suspected.
Magnetic resonance imaging may be more sensitive for detecting
early changes, yielding positive results several weeks before X-
rays. However it is not clear that diagnosing the process early will
influence long-term patient outcome, because no effective
treatments are available.
Currently only a small minority of long-stay intensive care
patients are followed up by the critical care service, and thus
there is no ‘bridge’ between the critical and rehabilitation
phases of illness. Recent studies have demonstrated that
survivors suffer long-term consequences that can have a
marked impact on their recovery and quality of life for years
after discharge, and a current paper highlights a specific
physical issue: heterotopic ossification (HO) [1].
Return to normal functional status is often slow, with different
rates of physical and psychological improvement [2-4]. Lack
of understanding and experience of possible long-term
sequelae of critical illness may hinder patient recovery further
because access to the full range of services required in the
rehabilitative phase may not be provided.
HO is a recognised condition in critical care patients, causing
significant long-term morbidity in up to 5% patients after a
prolonged stay [5]. The condition is not widely recognised
and may evade diagnosis, yet it may be a major cause of
impaired mobility and pain in the months after discharge [5].
The condition has been described in patients with head or
spinal cord injury, pancreatitis and acute respiratory distress
syndrome (ARDS), although any sedated patient is vulnerable
[6,7].
The presentation is non-specific, with pain, swelling, fever
and decreased joint mobility – common signs that may be
frequently overlooked. Furthermore, presentation may be
obscured by sedation or muscle relaxants.
Argyropoulou and colleagues [1] describe a series of 11
patients who developed HO of the knee during prolonged
critical care stay; head injury was the cause for admission in
most cases. They report early ‘lacy’ changes in the vastus
medialis and lateralis muscles on magnetic resonance
imaging (MRI) (T1-weighted and short TI inversion recovery
(STIR) images) and homogeneous high signal changes in the
medial portion of the vastus medialis. The authors report that
MRI changes occurred very rapidly after clinical suspicion of
the diagnosis, but X-ray changes were delayed for a further
23 days. On follow-up MRI scanning, the medial portion of
the vastus medialis had developed heterogeneous changes
suggestive of HO in all cases. X-rays at this time showed
calcification in the same position. This delay in X-ray
presentation is plausible, because substantial calcification of
the area needs to occur for X-ray changes to be evident. This
occurs at a relatively late phase of the disease. Histologically
the first changes are infiltration of the muscle by immature
connective tissue, fibroblasts and collagen fibres, and this
may be what the MRI changes are representing [8]. The
authors therefore suggest that MRI scanning should be
employed early to confirm the diagnosis, rather than waiting
for the delayed X-ray changes.
What causes muscle to calcify and turn to bone is still poorly
understood. Argyropoulou and colleagues give an account of
the hypothesised pathogenesis: dormant osteoprogenitor
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stem cells in soft tissue seem to be activated by bone
morphogenetic protein, the release of which is triggered by a
variety of stimuli (such as head injury) [9]. This results in
differentiation of these stem cells into osteoblasts, which go
on to form bone. The knee is commonly affected, in particular
the vastus medialis. The reason for this is not yet clear;
muscle atrophy after disuse predisposes to HO and this is
exaggerated in muscle rich in slow-twitch fibres, such as the
medial aspect of the vastus medialis.
Functional limitation resulting from HO and other factors
(such as muscle wasting and entrapment neuropathy) has
been shown to be significant even 1 year after discharge from
intensive care: ARDS survivors are only able to walk 66% of
predicted distance in 6 minutes, and only 49% return to work
in the first year [5]. It is therefore important to avoid and treat
HO where possible. During the acute inflammatory phase the
joint should be rested but passive exercising should begin as
soon as possible. Treatment modalities of established HO are
limited; non-steroidal anti-inflammatory drugs and irradiation
of the affected area have been suggested as options in HO
after hip replacement [10]. Surgical removal of excess bone
is an option, but only after full maturation has occurred or else
recurrence is inevitable [11]. After surgery, bisphosphates
may be used to prevent further recurrence [12]. However, no
therapies have been proven to be of benefit in avoiding or
halting the disease in critical care patients.
This leads us to ask whether early diagnosis by MRI scanning
is actually of any benefit. MRI scanning of the critically ill is
fraught with challenges, such as the need to use equipment
incorporating only non-ferrous metals. Many MRI scanners
are poorly equipped with invasive monitoring facilities,
meaning that only the most stable patients can be scanned
safely. In the above study, out of 670 patients screened for
HO, 31 were identified (clinically); only 11 were included and
deemed stable enough to be transferred to the MRI scanner.
Cost implications must also be considered.
If a clear therapeutic intervention could be employed to halt
the progression of HO, then, logically, early MRI scanning
would only be of benefit if a resultant therapeutic intervention
could halt the progression of HO. Currently no treatment can
claim to do this. Instead, the focus should probably be on
effective physiotherapy and joint exercise during the period of
immobility to try to prevent the condition from developing. A
well-formulated rehabilitation programme after discharge is
the best that can currently be offered to affected patients;
this may lead to accelerated physical and psychological
recovery [3]. Until the condition is better understood and
effective treatment is available, this should be the target of
our resources.
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